Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • bstephenwhite@gmail.com
    Junior Member
    • Nov 2013
    • 1

    edgeR spliceVariants: gene- and exon-level dispersion

    Hi,

    I'm trying to detect alternative splicing between 2 experimental conditions
    using edgeR's spliceVariants (and DE(X)Seq).

    For each gene, spliceVariants uses a single dispersion calculated by
    estimateExonGeneWiseDisp, which simply aggregates all exon counts
    within a gene and calculates a per-gene dispersion based on those
    aggregated counts. This seems highly anti-conservative (i.e., gives
    extremely low dispersions). The counts being fit are exon-level counts--
    i.e., smaller numbers with larger dispersions. Am I missing some theoretical
    or intuitive justification for this choice? Wouldn't a less severe
    anti-conservative choice be the min dispersion across all exons within
    the gene (still larger than that provided by estimateExonGeneWiseDisp)?
    While an intuitive conservative choice is the max?

    If I understand this statistical framework correctly, I should be able to use
    a per-exon dispersion--clearly this is possible if I take my tags to be exons,
    but in theory it should also be possible in the spliceVariants scenario in
    which the tags are genes, though the counts represent exons. DEXSeq
    appears to be doing this. Is there a straightforward means of doing this within edgeR? The interface to glmFit seems to preclude it.

    Thank you,
    Brian
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    You might have to ask this on the bioconductor email list so someone from Gordon Smyth's group can reply. I would be rather hesitant to rely on spliceVariants() for the reasons that you list.

    Comment

    • rboettcher
      Member
      • Oct 2010
      • 71

      #3
      Hi Brian,

      I am also interested in this topic, so could you please keep this thread updated in case you find your answer?

      Regards

      Comment

      • Gordon Smyth
        Member
        • Apr 2011
        • 91

        #4
        We have are most of the way through a major overall and improvement of edgeR's spliceVariants() function. We haven't made the new version public yet -- will do when it is stable.

        In the meantime, you might try the diffSplice() function in the limma package, which is very fast and controls the false discovery rate conservatively.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 11:41 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        35 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        45 views
        0 reactions
        Last Post SEQadmin2  
        Working...